Novo Nordisk A/S
Stocks making the biggest moves midday: Palantir, Moderna, Ulta Beauty, Alibaba and more
Check out the companies making headlines in midday trading. Global pharma stocks — Shares of several vaccine makers declined after President-elect Donald Trump selected prominent vaccine skeptic Robert F. Kennedy Jr. as health secretary on Thursday. Shares of Moderna and Pfizer slipped nearly 9% and 5%, respectively. BioNTech , which helped develop a Covid vaccine with […]
Read More
Philippe Laffont’s Coatue makes big bets on China and GLP-1 drugmakers in latest quarter
Philippe Laffont’s Coatue Management took several new stakes in major Chinese e-commerce companies and a couple of anti-obesity focused drugmakers in the third quarter, according to the latest 13F filing with the U.S. Securities and Exchange Commission. Laffont, one of the “Tiger Cub” fund managers who worked under the late Julian Robertson at Tiger Management, […]
Read More
Amgen stock falls as analysts mull over weight loss drug’s bone density data
Omar Marques | Lightrocket | Getty Images Shares of Amgen fell more than 7% Tuesday as analysts chewed over bone density loss data from an early-stage trial on its experimental weight loss injection, MariTide. One analyst said the additional data suggests a new potential safety risk tied to the drug. But others said the share […]
Read More
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Aykut Karahan | Istock | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Happy Friday! Buried in the election news this week was new data from drugmakers vying to enter the booming weight […]
Read More
Stocks making the biggest moves midday: Super Micro Computer, Tesla, Coinbase, Planet Fitness and more
Check out the companies making headlines in midday trading. Donald Trump trades — Individual stocks viewed as trades tied to Donald Trump’s election odds surged as the Republican clinched a return to the White House. Trump Media & Technology , majority owned by Trump himself, popped nearly 5%. Tesla , whose CEO publicly backed the […]
Read More
Stocks making the biggest moves premarket: Tesla, DJT, CVS Health, Dollar Tree and more
Check out the companies making headlines before the stock market opens: Crypto stocks — Shares of Coinbase surged 12% as investors cheered the prospect of a more supportive regulatory environment for cryptocurrency businesses under a second Donald Trump presidency. MicroStrategy , which trades as a high-beta play on the bitcoin price, gained 11% as bitcoin […]
Read More
European stocks head for lower open as global markets focus on U.S. vote count
Novo Nordisk quarterly profit meets expectations Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters Novo Nordisk on Wednesday reported third quarter earnings broadly in line with expectations and narrowed its 2024 full-year growth guidance. The Danish pharmaceutical giant said that its […]
Read More
Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
The “Wegovy” brand slimming syringe is sold in the Achat pharmacy in Mitte. The “Wegovy” slimming syringe has been available in Germany for a year. Jens Kalaene | Picture Alliance | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. […]
Read More
Novo Nordisk’s Ozempic and Wegovy now available in the U.S. after shortages, FDA says
Packages containing syringes of the medications Wegovy, Ozempic and Mounjaro at a shop in Mitte, Germany, July 11, 2024. Picture Alliance | Picture Alliance | Getty Images All doses of Novo Nordisk‘s highly popular weight loss injection Wegovy and diabetes drug Ozempic are now available in the U.S., according to an update on the U.S. […]
Read More
Novo Nordisk’s diabetes drug Ozempic may reduce the risk of Alzheimer’s disease, study says
Steve Christo – Corbis | Corbis News | Getty Images Novo Nordisk‘s blockbuster diabetes drug Ozempic may reduce the risk of developing Alzheimer’s disease, suggesting its potential to delay or prevent the memory-robbing condition, according to a study released Thursday. Semaglutide, the active ingredient in Ozempic, was associated with a 40% to 70% lower risk […]
Read More